Filter Results :

Your search for Immune returned 145 reports

Sort by


MedImmune, LLC - Product Pipeline Review - 2016

13 Apr 2016  |  Published by:  Global Markets Direct
Summary‘MedImmune, LLC - Product Pipeline Review - 2016’, provides an overview of the MedImmune, LLC’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by MedImmune, LLC, complete with analysis by stage of development,...

$ 1,500.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2016

22 Mar 2016  |  Published by:  Global Markets Direct
Summary‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2016’, provides an overview of the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) pipeline landscape. The report provides comprehensive information on the therap...

$ 2,000.00

Read More

Global Autoimmune Drugs Market 2016-2020

18 Mar 2016  |  Published by:  Technavio
About Autoimmune Diseases Drugs Autoimmune diseases are immunological disorders that occur when the immune system attacks and destroys healthy tissues in the body rather than foreign bodies, causing significant pain, inflammation, and organ damage. These diseases can affect the nervous syst...

$ 2,500.00

Read More

TapImmune Inc. (TPIV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

16 Mar 2016  |  Published by:  GlobalData
SummaryTapImmune Inc. (TapImmune) is a biotechnology company that develops peptide and gene based immunotherapeutics and vaccines for treatment of oncology and infectious disease. It conducts preclinical immunotherapeutic programs for clinical trials. TapImmune’s immunotherapy technologies are used ...

$ 250.00

Read More

NovImmune SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

15 Mar 2016  |  Published by:  GlobalData
SummaryNovImmune SA (NovImmune) is a drug discovery and development company that focuses on the discovery and development of antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders and cancer. Its pipeline products include NI-1801, NI-0401, NI-1701, NI-0501, NI-1401...

$ 250.00

Read More

MedImmune Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

14 Mar 2016  |  Published by:  GlobalData
SummaryMedImmune Limited (MedImmune), a subsidiary of AstraZeneca Plc is a biotechnology company that develops and commercializes small molecule and biologic prescription medicines for the prevention of respiratory tract disease caused by respiratory syncytial virus. The company's products include s...

$ 250.00

Read More

Neurimmune Holding AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

14 Mar 2016  |  Published by:  GlobalData
SummaryNeurimmune Holding AG (Neurimmune) is a biopharmaceutical company which undertakes the development of immunotherapeutics for the treatment and prevention of human disorders with focuses on neurodegenerative disorders. The company by utilizing its Reverse Translational Medicine...

$ 250.00

Read More

Autoimmune Disease Therapeutics - Global Market Outlook (2015-2022)

01 Mar 2016  |  Published by:  Stratistics MRC
According to Stratistics MRC, the Global Autoimmune Disease Therapeutics Market is accounted for $51.2 billion in 2015 and is expected to reach $82.13 billion by 2022 growing at a CAGR of 6.9% during the forecast period. Rising healthcare expenditure in the region is one of the key factors fueling t...

$ 4,150.00

Read More

Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

01 Jan 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Acquired (Autoimmune) Hemolytic Anemia-API Insights, 2015,report provides Acquired (Autoimmune) Hemolytic Anemia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File...

$ 1,250.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

01 Jan 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-API Insights, 2015,report provides Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) drugs marketed details and API Manufacturers details across the globe along with the location. The rep...

$ 1,250.00

Read More

Acquired (Autoimmune) Hemolytic Anemia-API Insights, 2014

01 Jan 2016  |  Published by:  DelveInsight
SummaryThe active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of t...

$ 1,250.00

Read More

Acquired (Autoimmune) Hemolytic Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jan 2016  |  Published by:  DelveInsight
Summary'Acquired (Autoimmune) Hemolytic Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the unders...

$ 2,000.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jan 2016  |  Published by:  DelveInsight
Summary'Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the re...

$ 2,000.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-Pipeline Insights, 2016

01 Jan 2016  |  Published by:  DelveInsight
Summary Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura). The main objective of this report to track competitor pipel...

$ 1,250.00

Read More

Primary Immune Deficiency (PID)-Pipeline Insights, 2016

01 Jan 2016  |  Published by:  DelveInsight
Summary Primary Immune Deficiency (PID)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Primary Immune Deficiency (PID). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-l...

$ 1,250.00

Read More
Total 145 records.